Kura Oncology (KURA) Reports Q1 Loss, Lags Revenue Estimates

  • Kura Oncology (KURA) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.59 per share a year ago.